T2 Biosystems solidified its position as a coronavirus stock on Wednesday morning when it announced the launch of its COVID-19 molecular diagnostic test.
Stocks closed up on Monday and shares were indicated up marginally on Tuesday morning. Investors are starting to see upside targets being issued for 2020 but there still many pressing issues and...
The top analyst upgrades, downgrades and initiations for Thursday included AbbVie, Ally Financial, Anthem, Caterpillar, CVS Health, Deere, Oracle, PayPal, Rite Aid, Square, Uber Technologies and...
The top analyst upgrades, downgrades and initiations for Wednesday included Alcoa, Apple, Ciena, Cisco Systems, Dave & Buster's, GameStop, Hilton Worldwide, Newmont Goldcorp, RH, Square and...
Stocks saw profit-taking on Tuesday, but the major indexes were up on Wednesday ahead of the Federal Reserve’s expected interest rate cut in the afternoon. Earnings season is proving to be...
The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines and Tesla.
The top analyst upgrades, downgrades and other research calls from Monday include AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp and Splunk.
T2 Biosystems saw its shares drop handily early on Friday after the firm announced that it would be pricing its secondary offering.
July 12, 2016: Just four stocks made new 52-week lows in Tuesday’s trading session. And only one of those trades more than 1 million shares on average every day. NYSE advancers and decliners by...
The top analyst upgrades, downgrades and initiations seen on Friday morning include Gold Fields, Humana, Intel, PayPal and Yelp,
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Arcelor Mittal, Chesapeake Energy, Domino's Pizza, Juniper Networks, 3M, QEP Resources, Starbucks and YuMe.
Friday’s top analyst upgrades, downgrades and initiations include Boeing, CVS, DuPont, Fitbit, LifeLock, Microsoft, NXP Semiconductors, Red Hat and Under Armour.
Tuesday's top analyst upgrades, downgrades and initiations include Altria, CEVA, CONSOL Energy, Enbridge Energy Partners, NVIDIA, UBS and Visa.
The unexpected reimbursement rate proposals by the Center for Medicaid hit the diagnostic sector on Monday.
T2 Biosystems was reiterated as Buy at Janney Capital, and the firm said that it sees a fair value estimate of $25.00 for this stock.